Palvella Therapeutics, Inc. (PVLA) vs Xencor, Inc. (XNCR)
A side-by-side comparison of Palvella Therapeutics, Inc. and Xencor, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
PVLA
Palvella Therapeutics, Inc.
$128.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
XNCR
Xencor, Inc.
$24.36HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — PVLA vs XNCR
growth of $100 · dividends reinvested · last 2yPVLA +677.4% (+178.8%/yr)XNCR +1.7% (+0.8%/yr)PVLA compounded faster over this window
Log scale — wide-divergence pair
PVLA XNCR
PVLA vs XNCR: by the numbers
- •PVLA is the larger company ($1.84B vs $1.81B market cap).
- •Both run net losses; PVLA's is the smaller (0.00% vs -155.59% net margin).
Metrics side by side
Valuation
| Metric | PVLA | XNCR |
|---|---|---|
| P/S ratio | N/A | 17.21 |
| P/B ratio | 8.47 | 3.59 |
Profitability
| Metric | PVLA | XNCR |
|---|---|---|
| Gross margin | 0.00% | 91.63% |
| Operating margin | 0.00% | -141.35% |
| Net margin | 0.00% | -155.59% |
| ROE | -28.45% | -32.46% |
| ROIC | -23.90% | -33.60% |
Growth (annualized)
| Metric | PVLA | XNCR |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 0.47% |
| Total return CAGR (5Y) | N/A | -6.46% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.